Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor

Journal of Virology

Volumn 74, Issue 21, 2000, Pages 10055-10062

  Wunschmann, S ^a   Medh, J D ^a   Klinzmann, D ^a   Schmidt, W N ^a   Stapleton, J T ^a  

^a Department of Internal Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; CELL SURFACE; FLOW CYTOMETRY; HEPATITIS C VIRUS; IMMUNOASSAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; SUCROSE GRADIENT; VIRUS ENVELOPE; VIRUS PARTICLE;

ANIMAL; ANTIGENS, CD; CELL LINE; ENDORIBONUCLEASES; FIBROBLASTS; HEPACIVIRUS; HUMAN; MICE; MICROSCOPY, CONFOCAL; PROTEIN TRANSPORT; RECEPTORS, LDL; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED; VIRAL ENVELOPE PROTEINS;

EID: 0033781909     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.21.10055-10062.2000     Document Type: Article

References (56)

1. Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cells subsets
2. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor
3. A role for hepatitis C virus infection in type II cryoglobulinemia
4. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients
5. Posttransfusion non-A, non-B hepatitis in chimpanzees: Physicochemical evidence that the tubule forming agent is a small, enveloped virus
6. Buoyant density of the factor CIII-derived isolate in sucrose
7. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
8. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloraform extraction
9. A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate
10. In vitro infection of peripheral blood mononuclear cells by hepatitis C virus
11. 2+ concentration to initiate their replication cycle
12. Hepatitis C: Progress and problems
13. Antibodies against hepatitis C virus in mixed cryoglobulinemia patients
14. Association between hepatitis C virus and mixed cryoglobulinemia
15. Functional analysis of cell surface-expresseds hepatitis C virus E2 glycoprotein
16. Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C
17. Suramin blocks hepatitis C binding to human hepatoma cells in vitro
18. Specific binding of hepatitis C virus to the Fc fragment of immunoglobulin molecules
19. Equilibrium centrifugation studies of hepatitis C virus: Evidence for circulating immune complexes
20. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia
21. Hepatitis C: The clinical spectrum of disease
22. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate
23. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR
24. CD81 (TAPA-1): A molecule involved in signal transduction and cell adhesion in the immune system
25. CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses
26. Normal lymphocyte development but delayed humoral immune response in CD81-null mice
27. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection
28. Characterization of monoclonal antibodies against human low density lipoprotein
29. Low-density lipoprotein receptor as a candidate receptor for hepatitis C virus
30. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication
31. Modification of membrane permeability during Semliki Forest virus infection
32. Proteins are cointernalized with virion particles during early infection
33. Cell surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines
34. Structure-function analysis of hepatitis C virus envelope-CD81 binding
35. Binding of hepatitis C virus to CD81
36. Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins
37. Microbial adherence to and invasion through proteoglycans
38. Direct detection of hepatitis C virus (HCV) RNA from whole blood, and comparison with HCV RNA in plasma and peripheral blood mononuclear cells
39. Hepatitis C infection and cryoglobulinemia: Analysis of whole blood and plasma HCV RNA concentration and correlation with liver histology
40. Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fractions: Plasma HCV RNA analysis underestimates circulating virus load
41. Role of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans
42. Establishment of persistent hepatitis C virus infection and replication in vitro
43. Hepatitis C virus: Detection of intracellular virus particles by electron microscopy
44. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line
45. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro
46. Prospective comparison of whole blood and plasma hepatitis C virus RNA detection systems: Improved detection using whole blood as the source of viral RNA
47. Cell fusion activity of hepatitis C virus envelope-CD81 binding
48. Association of hepatitis C virus in human sera with beta-lipoproteins
49. Density heterogeneities of hepatitis C virus in human sera due to binding of beta-lipoproteins and immunoglobulins
50. Clinical outcomes after transfusion-associated hepatitis C
51. 2+ and monoclonai antibodies, but not lipoproteins
52. Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells
53. Fluorescence-based quantitative methods for detecting human immunodeficiency virus type 1-induced syncytia
54. Visualization and characterization of GB virus C (hepatitis G virus) particles: Evidence for a nucleocapsid
55. Characterization of hepatitis G virus (GB-C virus) particles: Evidence for a nucleocapsid and expression of sequences upstream of the El protein
56. Full-length GB virus C (hepatitis G Virus) RNA transcripts are infectious in primary CD4-positive T cells